Martine Cools
Overview
Explore the profile of Martine Cools including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1517
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stolk T, van Mello N, Boogers L, Meissner A, Huirne J, Fisher A, et al.
J Sex Med
. 2025 Mar;
PMID: 40052542
Background: Gender-affirming treatment for transgender and gender-diverse (TGD) adolescents can consist of puberty suppression (PS) and gender-affirming hormone treatment (GAHT), which may affect fertility. Aim: This study aims to evaluate...
2.
Boogers L, Bruggenwirth H, Wolffenbuttel K, Hersmus R, Bryce J, Ahmed S, et al.
Eur J Endocrinol
. 2025 Jan;
192(1):34-45.
PMID: 39782875
Objective: 17β-Hydroxysteroid dehydrogenase 3 deficiency (17β-HSDD) and 5α-reductase type 2 deficiency (5α-RD) are rare 46,XY differences of sex development (DSD). This study aims to enlarge the limited knowledge on long-term...
3.
Hannema S, Busiah K, Butler G, Claahsen-van de Grinten H, Cools M, Gawlik-Starzyk A, et al.
Horm Res Paediatr
. 2024 Dec;
:1-27.
PMID: 39622214
No abstract available.
4.
Staels W, De Schepper J, Becker M, Lysy P, Klink D, Logghe K, et al.
Front Endocrinol (Lausanne)
. 2024 Oct;
15:1459998.
PMID: 39415786
Growth hormone (GH) deficiency (GHD) in children and adolescents can vary in severity and origin, with GH replacement therapy proving effective in achieving genetic target height. Optimal outcomes are seen...
5.
Tseretopoulou X, Ali S, Bryce J, Amin N, Atapattu N, Bachega T, et al.
J Endocr Soc
. 2024 Sep;
8(10):bvae145.
PMID: 39258010
Background: It is unclear whether targeted monitoring of acute adrenal insufficiency (AI) related adverse events (AE) such as sick day episodes (SDEs) and hospitalization rate in congenital adrenal hyperplasia (CAH)...
6.
Syryn H, Van de Velde J, De Clercq G, Verdin H, Dheedene A, Peelman F, et al.
Hum Reprod
. 2024 Sep;
39(10):2353-2363.
PMID: 39222519
Study Question: Does RXFP2 disruption impair male fertility? Summary Answer: We identified biallelic variants in RXFP2 in patients with male infertility due to spermatogenic arrest at the spermatid stage, supporting...
7.
Patjamontri S, Lucas-Herald A, Bryce J, van den Akker E, Cools M, Globa E, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39213311
Introduction: Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males. Objectives: To assess the management of gynecomastia in male...
8.
Brachet C, Laemmle A, Cools M, Sauter K, De Baere E, Vanlander A, et al.
Eur J Endocrinol
. 2024 Aug;
191(2):144-155.
PMID: 39097530
Objective: Adrenal cortisol production occurs through a biosynthetic pathway which depend on NADH and NADPH for energy supply. The mitochondrial respiratory chain and the reactive oxygen species (ROS) detoxification system...
9.
Boogers L, Wiepjes C, Staphorsius A, Klink D, Ciancia S, Romani A, et al.
J Sex Med
. 2024 Mar;
21(4):350-356.
PMID: 38427555
Background: Knowledge regarding the effects and side effects of gender-affirming hormone therapy (GAHT) in adults is rapidly growing, partly through international research networks such as the European Network for the...
10.
Cools M, Cheng E, Hall J, Alderson J, Amies Oelschlager A, Balen A, et al.
Horm Res Paediatr
. 2024 Feb;
PMID: 38310850
Background: In the last 15 years, the care provided for individuals born with differences of sex development (DSD) has evolved, with a strong emphasis on interdisciplinary approaches. However, these developments...